| Epratuzumab in Treating Patients With Non-Hodgkin's Lymphoma (NCT00022685) | Jonsson Comprehensive Cancer Center | 2001-09-01 |
| Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Biological Therapy in Treating Patients With Solid Tumors or Lymphoma (NCT00027937) | Fred Hutchinson Cancer Center | 2001-08-01 |
| Peripheral Stem Cell Transplantation Followed By Infusion of White Blood Cells in Treating Patients With AIDS-Related Lymphoma (NCT00024128) | AIDS Malignancy Consortium | 2001-08-01 |
| Radiolabeled Monoclonal Antibody in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT00033423) | University of Alabama at Birmingham | 2001-08-01 |
| Total-Body Irradiation and Chemotherapy Followed By Donor Bone Marrow Transplant in Treating Young Patients With Hematologic Cancer (NCT00028730) | Memorial Sloan Kettering Cancer Center | 2001-08-01 |
| Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the Skin (NCT00023790) | Case Comprehensive Cancer Center | 2001-08-01 |
| Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer (NCT00027560) | Memorial Sloan Kettering Cancer Center | 2001-07-01 |
| Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients (NCT00195533) | Wyeth is now a wholly owned subsidiary of Pfizer | 2001-07-01 |
| Using Fludarabine and Melphalan Conditioning Regimen for CLL,Lymphoma,Multiple Myeloma (NCT00772811) | Cooperative Study Group A for Hematology | 2001-07-01 |
| Combination Chemotherapy and Peripheral Stem Cell Transplant in Treating Patients With Relapsed Hodgkin's Lymphoma (NCT00025636) | German Hodgkin's Lymphoma Study Group | 2001-07-01 |
| Safety and Efficacy of Campath in Nonmyeloablative Transplantation (NCT00038844) | M.D. Anderson Cancer Center | 2001-06-01 |
| Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies (NCT00050687) | Titan Pharmaceuticals | 2001-06-01 |
| Chemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma (NCT00020943) | Alliance for Clinical Trials in Oncology | 2001-06-01 |
| Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma (NCT00026208) | Stanford University | 2001-06-01 |
| TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma (NCT00002757) | Children's Oncology Group | 2001-06-01 |
| Combination Chemotherapy With or Without Rituximab in Non-Hodgkin's Lymphoma (NCT00064116) | NCIC Clinical Trials Group | 2001-05-08 |
| Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer (NCT00237627) | UNC Lineberger Comprehensive Cancer Center | 2001-05-01 |
| Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma (NCT00006760) | Children's Oncology Group | 2001-05-01 |
| Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS (NCT00025662) | National Heart, Lung, and Blood Institute (NHLBI) | 2001-05-01 |
| Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer (NCT00290641) | Masonic Cancer Center, University of Minnesota | 2001-04-01 |
| Monoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent Lymphoma (NCT00006009) | Stanford University | 2001-04-01 |
| Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies (NCT00013533) | National Cancer Institute (NCI) | 2001-03-14 |
| Rituximab and ABVD for Hodgkin's Patients (NCT00504504) | M.D. Anderson Cancer Center | 2001-03-01 |
| S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma (NCT00006721) | SWOG Cancer Research Network | 2001-03-01 |
| Monoclonal Antibody Therapy, Paclitaxel, and Cyclosporine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma (NCT00009776) | University of California, Davis | 2001-03-01 |
| Caspofungin Acetate in Treating Children With Fever and Neutropenia (NCT00020527) | National Cancer Institute (NCI) | 2001-03-01 |
| VNP40101M in Treating Patients With Advanced Solid Tumors or Lymphomas (NCT00025129) | Vion Pharmaceuticals | 2001-03-01 |
| Monoclonal Antibody Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma (NCT00008021) | University of California, Davis | 2001-02-01 |
| Fludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplant in Treating Patients With Leukemia or Lymphoma (NCT00006252) | Cancer and Leukemia Group B | 2001-02-01 |
| Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III, Stage IV, or Recurrent Follicular Lymphoma (NCT00020462) | National Cancer Institute (NCI) | 2001-02-01 |
| Combination Chemotherapy Plus Filgrastim With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma (NCT00028717) | Commissie Voor Klinisch Toegepast Onderzoek | 2001-02-01 |
| Chemotherapy and Photodynamic Therapy in Treating Patients With Cutaneous T-Cell Lymphoma (NCT00030589) | Millennix | 2001-02-01 |
| Safety and Immunogenicity of Chiron's Investigational H. Pylori Vaccine in Healthy Adults (NCT00613665) | Novartis Vaccines | 2001-02-01 |
| Radiation Therapy in Relapsed or Refractory Non-Hodgkin's Lymphoma Who Have Undergone Stem Cell Transplantation (NCT00031668) | NCIC Clinical Trials Group | 2001-01-31 |
| Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma (NCT00026429) | Pharmatech Oncology | 2001-01-01 |
| Involved-Field Radiation Therapy in Treating Patients With Previously Untreated Stage I or Stage II Low-Grade Non-Hodgkin's Lymphoma (NCT00014326) | European Organisation for Research and Treatment of Cancer - EORTC | 2001-01-01 |
| Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma (NCT00052936) | German High-Grade Non-Hodgkin's Lymphoma Study Group | 2001-01-01 |
| Combination Chemotherapy in Hodgkin's Disease or Non-Hodgkin's Lymphoma Not Responding to Previous Treatment (NCT00014209) | NCIC Clinical Trials Group | 2000-12-12 |
| Chemotherapy Followed by Radiation Therapy and Peripheral Stem Cell Transplant Compared With Chemotherapy Plus Interferon Alfa in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma (NCT00016887) | German Low Grade Lymphoma Study Group | 2000-12-01 |
| Pentostatin and Rituximab in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (NCT00026351) | Pharmatech Oncology | 2000-12-01 |
| Music Therapy to Ease Pain and Emotional Distress in Patients With Hematologic Cancer Who Are Undergoing High-Dose Therapy and Stem Cell Transplantation (NCT00014482) | Memorial Sloan Kettering Cancer Center | 2000-12-01 |
| ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or Lymphoma (NCT00016172) | Memorial Sloan Kettering Cancer Center | 2000-11-01 |
| Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer (NCT00054327) | Case Comprehensive Cancer Center | 2000-11-01 |
| Monoclonal Antibody Therapy in Treating Patients With Recurrent or Refractory Lymphoma (NCT00007956) | National Cancer Institute (NCI) | 2000-11-01 |
| Combination Chemotherapy Followed By Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Non-Hodgkin's Lymphoma (NCT00017290) | Genitope Corporation | 2000-11-01 |
| Busulfan in Treating Children and Adolescents With Refractory CNS Cancer (NCT00006246) | Pediatric Brain Tumor Consortium | 2000-11-01 |
| Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma (NCT00006747) | Alliance for Clinical Trials in Oncology | 2000-11-01 |
| Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory AIDS-Related Lymphoma (NCT00005824) | AIDS Malignancy Consortium | 2000-11-01 |
| BMS-247550 in Treating Patients With Advanced Cancers (NCT00006221) | National Cancer Institute (NCI) | 2000-11-01 |
| Vaccine Therapy Following Chemotherapy & Peripheral Stem Cell Transplantation in Treating Non-Hodgkin's Lymphoma (NCT00006478) | University of Nebraska | 2000-10-11 |
| S0019 Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT00006708) | SWOG Cancer Research Network | 2000-10-01 |
| Combination Chemotherapy Plus Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma (NCT00005601) | Alliance for Clinical Trials in Oncology | 2000-10-01 |
| Treatment of Disseminated High Grade Lymphoma (NCT00536393) | French Innovative Leukemia Organisation | 2000-10-01 |
| Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment (NCT00006348) | Alliance for Clinical Trials in Oncology | 2000-10-01 |
| Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation (NCT00005946) | University of Maryland, Baltimore | 2000-10-01 |
| Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT00014664) | PDL BioPharma, Inc. | 2000-10-01 |
| Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (NCT00014560) | Dartmouth-Hitchcock Medical Center | 2000-09-28 |
| Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia (NCT00005977) | Children's Oncology Group | 2000-09-01 |
| Combination Chemotherapy Plus Rituximab in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma (NCT00007865) | University of Nebraska | 2000-09-01 |
| Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma (NCT00012051) | Commissie Voor Klinisch Toegepast Onderzoek | 2000-09-01 |
| Biological Therapy After Chemotherapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT00012207) | Fred Hutchinson Cancer Center | 2000-09-01 |
| Phase I/II Study of Pentostatin Combined With Tacrolimus and Mini-Methotrexate for GVHD Prevention After MUD BMT (NCT00506922) | M.D. Anderson Cancer Center | 2000-09-01 |
| Beta Alethine in Treating Patients With Low-Grade Lymphoma (NCT00007839) | LifeTime Pharmaceuticals | 2000-08-01 |
| Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma (NCT00005985) | Masonic Cancer Center, University of Minnesota | 2000-08-01 |
| Tipifarnib in Treating Patients With Advanced Hematologic Cancer (NCT00005967) | National Cancer Institute (NCI) | 2000-08-01 |
| Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors (NCT00004157) | Fred Hutchinson Cancer Center | 2000-08-01 |
| Alemtuzumab in Treating Patients With Relapsed or Refractory Advanced Mycosis Fungoides or Sézary Syndrome (NCT00057967) | Northwestern University | 2000-07-01 |
| Zidovudine Plus Interleukin-2 and Ganciclovir in Treating Patients With AIDS-Related Primary Central Nervous System Lymphoma (NCT00006264) | AIDS Malignancy Consortium | 2000-07-01 |
| Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma (NCT00006125) | Alliance for Clinical Trials in Oncology | 2000-07-01 |
| Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders (NCT00582621) | Memorial Sloan Kettering Cancer Center | 2000-07-01 |
| Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma (NCT00006029) | Alliance for Clinical Trials in Oncology | 2000-07-01 |
| Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon (NCT00010283) | Fred Hutchinson Cancer Center | 2000-07-01 |
| Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma (NCT00006102) | National Cancer Institute (NCI) | 2000-07-01 |
| Cognitive Functioning and Quality of Life in CNS Lymphoma (NCT00581737) | Memorial Sloan Kettering Cancer Center | 2000-07-01 |
| Cyclophosphamide W/or W/Out Rituximab and Peripheral Stem Cell Transplantation in Patients With Recurrent Non-Hodgkin's Lymphoma (NCT00028665) | Case Comprehensive Cancer Center | 2000-06-01 |
| Non-Ablative Allo HSCT For Hematologic Malignancies or SAA (NCT00006379) | Case Comprehensive Cancer Center | 2000-06-01 |
| Arsenic Trioxide in Treating Patients With Relapsed or Refractory Hodgkin's Disease (NCT00005595) | Northwestern University | 2000-06-01 |
| Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer (NCT00365287) | Masonic Cancer Center, University of Minnesota | 2000-06-01 |
| Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed Malignancies (NCT00038207) | M.D. Anderson Cancer Center | 2000-06-01 |
| Liposomal Vincristine in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma (NCT00006383) | Inex Pharmaceuticals | 2000-06-01 |
| Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic Lymphoma (NCT00004228) | Children's Oncology Group | 2000-06-01 |
| Yttrium Y 90 Ibritumomab Tiuxetan, Etoposide, Cyclophosphamide, and an AHSCT in Non-Hodgkin's Lymphoma Patients (NCT00562978) | City of Hope Medical Center | 2000-05-16 |
| Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Non-Hodgkin's Lymphoma (NCT00006250) | Lymphoma Trials Office | 2000-05-01 |
| Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Previously Untreated Aggressive Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma (NCT00005964) | Alliance for Clinical Trials in Oncology | 2000-05-01 |
| Study for Newly Diagnosed Follicular Lymphoma Patients With a Large Tumor Burden (NCT00136552) | Lymphoma Study Association | 2000-05-01 |
| Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer (NCT00006019) | Memorial Sloan Kettering Cancer Center | 2000-05-01 |
| PS-341 in Treating Patients With Hematologic Cancer (NCT00006098) | Memorial Sloan Kettering Cancer Center | 2000-04-01 |
| Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia (NCT00005609) | Eastern Cooperative Oncology Group | 2000-04-01 |
| Monoclonal Antibody Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplant in Non-Hodgkin's Lymphoma (NCT00006695) | University of Nebraska | 2000-04-01 |
| Quality of Life in Children Treated for Cancer (NCT00005881) | Children's Oncology Group | 2000-04-01 |
| Radiolabeled Monoclonal Antibody Therapy and High-Dose Chemotherapy Followed By Autologous Peripheral Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT00058292) | Northwestern University | 2000-04-01 |
| Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter (NCT00006083) | Jonsson Comprehensive Cancer Center | 2000-04-01 |
| S9901 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Men With Stage III or Stage IV Hodgkin's Disease (NCT00005090) | SWOG Cancer Research Network | 2000-04-01 |
| S0014 Combination Chemotherapy Plus Rituximab and Radiation Therapy in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma (NCT00005089) | SWOG Cancer Research Network | 2000-04-01 |
| Arsenic Trioxide in Treating Young Patients With Refractory Leukemia or Lymphoma (NCT00020111) | National Cancer Institute (NCI) | 2000-03-01 |
| Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment (NCT00005639) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2000-03-01 |
| Analysis of Genes Present in Cutaneous T-cell Lymphoma Cells (NCT00020072) | National Cancer Institute (NCI) | 2000-03-01 |
| Monoclonal Antibody Therapy in Treating Patients With Recurrent Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma (NCT00004858) | Parker Hughes Cancer Center | 2000-03-01 |
| Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr Virus in Patients Who Have Undergone Transplantation (NCT00005606) | Northwestern University | 2000-02-01 |
| Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma (NCT00006373) | H. Lee Moffitt Cancer Center and Research Institute | 2000-02-01 |